LS Investment Advisors LLC Has $925,000 Position in Humana Inc. (HUM)
LS Investment Advisors LLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 1.2% during the second quarter, Holdings Channel reports. The institutional investor owned 5,144 shares of the insurance provider’s stock after buying an additional 63 shares during the period. LS Investment Advisors LLC’s holdings in Humana were worth $925,000 as of its most recent filing with the SEC.
Several other large investors also recently bought and sold shares of the stock. Daiwa SB Investments Ltd. boosted its stake in Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares in the last quarter. Bessemer Group Inc. boosted its stake in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares in the last quarter. Spark Investment Management LLC bought a new stake in Humana during the first quarter valued at approximately $274,000. Trust Co boosted its stake in Humana by 12.4% in the first quarter. Trust Co now owns 1,720 shares of the insurance provider’s stock valued at $315,000 after buying an additional 190 shares in the last quarter. Finally, Advisor Partners LLC boosted its stake in Humana by 9.3% in the first quarter. Advisor Partners LLC now owns 2,211 shares of the insurance provider’s stock valued at $405,000 after buying an additional 188 shares in the last quarter. 93.24% of the stock is owned by hedge funds and other institutional investors.
Humana Inc. (NYSE:HUM) traded down 0.39% during mid-day trading on Tuesday, hitting $177.53. The stock had a trading volume of 1,618,709 shares. The company has a 50 day moving average price of $176.81 and a 200 day moving average price of $175.92. The stock has a market cap of $26.46 billion, a P/E ratio of 27.27 and a beta of 0.90. Humana Inc. has a one year low of $150.00 and a one year high of $191.65.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. The business earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.67 EPS. On average, equities analysts anticipate that Humana Inc. will post $9.24 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be issued a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.65%. Humana’s payout ratio is 18.18%.
HUM has been the subject of several recent analyst reports. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a research note on Tuesday, October 4th. Credit Suisse Group AG reissued a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research note on Saturday, July 9th. Royal Bank Of Canada lifted their price objective on Humana from $220.00 to $224.00 and gave the company an “outperform” rating in a research note on Friday, July 22nd. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a research note on Tuesday, June 21st. Five equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $201.00.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.